Spinal Muscular Atrophy Drug Approval
Spinraza was developed by Ionis Pharmaceuticals of Carlsbad in partnership with Biogen Inc. In July 2016, Biogen decided to license Spinraza. During Spinraza’s development, Ionis…
Clinical Trial
Alzheimer’s Disease Could Be Lowered with Cholesterol Drugs
More than five million U.S. residents suffer from Alzheimer’s disease and while much is known about the disease, scientists have had no success in development…
Lucentis And Avastin Effectiveness In Treating Macular Degeneration
Age-related macular degradation (AMD) is the most common reason for vision loss or blindness in senior U.S. citizens. This disease spurs the growth of uncommon…
Alcohol Dependence Could Be Treated With Parkinson’s Disease Medication
Researchers suggest that there is a new possible effective way to treat an alcohol dependence. According to a small study, inhibition of the enzyme, which…
“Virtual” Clinical Trial Is Conducted By Pfizer
On June 7, Pfizer Inc., under the investigational new drug application, conducted first in the history electronic clinical trial. This trial is unique because it…
Three Brand New Weight-Loss Drugs
One of the Food and Drug administration groups will have a meeting on July 15, 2010, to discuss one of the weight-loss medications which are…
Amgen’s Prolia™ (denosumab) Was Approved By FDA
On June 1, 2010, Amgen inc. announced, that the U.S. Food and Drug Administration (FDA) has approved Prolia™ (denosumab) for the treatment of postmenopausal women…